Oxytocin nasal spray ( DrugBank: Oxytocin )


2 diseases
告示番号疾患名(ページ内リンク)臨床試験数
72下垂体性ADH分泌異常症1
193プラダー・ウィリ症候群1

72. 下垂体性ADH分泌異常症


臨床試験数 : 41 薬物数 : 27 - (DrugBank : 8) / 標的遺伝子数 : 7 - 標的パスウェイ数 : 10
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04789148
(ClinicalTrials.gov)
June 20235/3/2021Effects of Intranasal Oxytocin in Patients With Central Diabetes InsipidusEffects of Intranasal Oxytocin in Patients With Central Diabetes Insipidus - A Pilot StudyCentral Diabetes InsipidusDrug: Oxytocin nasal sprayElizabeth Austen LawsonNULLNot yet recruiting18 Years60 YearsAll30Phase 1United States

193. プラダー・ウィリ症候群


臨床試験数 : 113 薬物数 : 111 - (DrugBank : 26) / 標的遺伝子数 : 48 - 標的パスウェイ数 : 102
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05298085
(ClinicalTrials.gov)
April 5, 202217/3/2022Effect of Intranasal Oxytocin on Dysphagia in Children and Adolescents With Prader-Willi SyndromeEffect of Intranasal Oxytocin on Dysphagia Related to Oropharyngo-oesophageal Dysmotility in Children and Adolescents With Prader-Willi Syndrome: a Phase 2B StudyPrader-Willi SyndromeDrug: Oxytocin nasal spray;Drug: PlaceboUniversity Hospital, ToulouseNULLActive, not recruiting2 Years17 YearsAll25Phase 2/Phase 3France